Henry Schein, Inc. (NASDAQ:HSIC) Receives $78.89 Consensus PT from Brokerages

Henry Schein, Inc. (NASDAQ:HSIC) has earned an average rating of “Moderate Buy” from the eleven ratings firms that are covering the company, MarketBeat Ratings reports. Six investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating on the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is $78.89.

Several brokerages have weighed in on HSIC. Barrington Research restated an “outperform” rating and set a $82.00 price objective on shares of Henry Schein in a research note on Wednesday, November 6th. StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Evercore ISI upped their price objective on shares of Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. Finally, Mizuho began coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 target price on the stock.

Henry Schein Trading Down 2.4 %

NASDAQ:HSIC opened at $68.95 on Tuesday. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. Henry Schein has a one year low of $63.67 and a one year high of $82.63. The company has a market cap of $8.60 billion, a PE ratio of 28.37, a PEG ratio of 2.31 and a beta of 0.87. The firm has a 50-day moving average of $72.43 and a 200-day moving average of $70.13.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, topping analysts’ consensus estimates of $1.17 by $0.05. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. During the same period in the previous year, the company posted $1.32 EPS. The company’s revenue for the quarter was up .4% on a year-over-year basis. As a group, equities research analysts expect that Henry Schein will post 4.78 EPS for the current fiscal year.

Insider Transactions at Henry Schein

In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of the company’s stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $75.00, for a total transaction of $918,000.00. Following the sale, the chief operating officer now directly owns 87,706 shares of the company’s stock, valued at $6,577,950. This represents a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.14% of the stock is currently owned by company insiders.

Institutional Trading of Henry Schein

Several hedge funds and other institutional investors have recently modified their holdings of the business. Cromwell Holdings LLC raised its stake in shares of Henry Schein by 93.4% during the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after purchasing an additional 170 shares during the period. Summit Securities Group LLC bought a new stake in shares of Henry Schein during the second quarter valued at about $31,000. Blue Trust Inc. lifted its holdings in shares of Henry Schein by 104.2% in the second quarter. Blue Trust Inc. now owns 931 shares of the company’s stock worth $60,000 after buying an additional 475 shares in the last quarter. Farther Finance Advisors LLC boosted its position in shares of Henry Schein by 58.9% in the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock valued at $68,000 after acquiring an additional 346 shares during the period. Finally, Livforsakringsbolaget Skandia Omsesidigt grew its stake in Henry Schein by 282.1% during the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,490 shares of the company’s stock valued at $109,000 after acquiring an additional 1,100 shares in the last quarter. Institutional investors own 96.62% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.